The cytoplasmic to nuclear MBNL1 ratio was also determined; a statistically significant increase in the nuclear fraction was observed with PACT RNAi treatment in all cell lines tested with the greatest effect seen in DM1 cells (Fig 3F). The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.